Latest Alleghany Corp (Y) Headlines Tower Group Down to

New Post Public Reply Private Reply Replies (0) Message Board

Mar 14, 2014 at 10:33 AM

Latest Alleghany Corp (Y) Headlines

Tower Group Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 3:40PM CDT
On Mar 11, 2014, Zacks Investment Research downgraded Tower Group Internationalto a Zacks Rank #4 (Sell).

Atlas Financial Shares Gain on Solid Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 9:25AM CDT
Shares of Atlas Financial continue to rally riding on the strength of fourth-quarter earnings results. Shares surged almost 12.3% since the earnings announcement on Mar 10.

First American Financial (FAF) in Focus: Stock Adds 6.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:37AM CDT
First American Financial Corporation was a big mover last session, as the company saw its shares rise more than 6% on the day.

Atlas Financial: A Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 5:50PM CDT
On Mar 12, Zacks Investment Research upgraded Atlas Financial to a Zacks Rank #1 (Strong Buy) owing to solid fourth quarter 2013 results.

Earnings, Revs Rise at Safty Insurance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 12:17PM CDT
Safty Insurance reported fourth-quarter 2013 net earnings of 76 cents per share. The number improved 22.6% year over year.

Atlas Financial Holdings (AFH) in Focus: Stock Moves 6.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:04AM CDT
Atlas Financial Holdings, Inc. was a big mover last session, as the company saw its shares rise over 6% on the day.

Can AmTrust Financial (AFSI) Continue to Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:55AM CDT
AmTrust Financial has seen its Zacks Rank surge over the past four weeks, moving from Buy territory to its current position as a Strong Buy

Why OneBeacon Insurance (OB) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:47AM CDT
OneBeacon Insurance has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Buy

AXIS Capital Prices Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 5:20PM CST
A wholly-owned subsidiary of AXIS Capital, AXIS Specialty Finance has priced the offerings of its senior unsecured notes.

Berkshire Hathaway Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 2:20PM CST
On Mar 6, 2014, shares of Berkshire Hathaway touched an all time high of $121.44. Shares gained nearly 17% in the 1-year period.

Fitch Affirms Alleghany's Ratings; Outlook Stable
Business Wire - Thu Mar 06, 9:50AM CST
Fitch Ratings has affirmed the ratings of Alleghany Corporation (Alleghany) as follows:

Berkshire Hathaway Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 9:30AM CST
On Mar 4, Zacks Investment Research upgraded Berkshire Hathaway to a Zacks Rank #1 (Strong Buy).

Why Alleghany (Y) Stock Might be a Great Pick - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:39AM CST
Alleghany is seeing solid earnings estimate revision activity and also has a great company from a Zacks Industry Rank perspective

ASCC: Award-Winning Spirit Leads Gluten-Free Sector
Business Wire - Tue Mar 04, 4:00AM CST
Consumers are increasingly turning to higher quality gluten-free alternatives, and revenues in the sector are projected to soar past the $15 billion mark in the next two years. With its award-winning, gluten-free RWB Ultra-Premium Handcrafted Vodka, the Aristocrat Group Corp. (OTCBB: ASCC) is targeting a share of the gluten-free marketplace.

Q4 Earnings Beat, Higher Revs at Berkshire - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 9:50AM CST
Berkshire's fourth-quarter earnings significantly beat the Zacks Consensus Estimate on higher revenues.

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Friday

Alleghany's Earnings Lag, Revs Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:00AM CST
Alleghany's operating earnings of $6.99 per share in the fourth quarter of 2013 lagged the Zacks Consensus Estimate but rebounded from the year-ago quarter's loss of $5.40 per share.

Alleghany Corporation Reports 2013 Fourth Quarter And Full Year Results -- Notice
PR Newswire - Tue Feb 25, 3:16PM CST
Alleghany Corporation (NYSE-Y) today reported its financial results for the three months and year ended December 31, 2013. A complete, full-text news release for Alleghany's 2013 fourth quarter and full year results is available on Alleghany's website at www.alleghany.com and is also contained in a Current Report on Form 8-K that has been filed with the U.S. Securities and Exchange Commission (the "SEC") and is available on the SEC's website at www.sec.gov.

Alleghany Corporation to Present at the Bank of America Merrill Lynch 2014 Insurance Conference
PR Newswire - Fri Feb 07, 3:18PM CST
Alleghany Corporation (NYSE: Y) announced today that Weston M. Hicks, its President and chief executive officer, will present at the Bank of America Merrill Lynch 2014 Insurance Conference on February 12, 2014. The presentation is expected to begin at approximately 4:05 p.m. Eastern Time. The presentation will include an overview of Alleghany's businesses, a discussion of its financial condition and its outlook going forward.

Alleghany Corporation To Announce Fourth Quarter and Fiscal Year 2013 Results On February 25, 2014
PR Newswire - Fri Jan 24, 11:31AM CST
Alleghany Corporation (NYSE-Y) will release its financial results for the fourth quarter and 2013 fiscal year after the market closes on Tuesday, February 25, 2014. In conjunction with the release, Alleghany will post its financial supplement to the company's web-site at www.alleghany.com.

Alleghany Corp. (Y) Stock Research Links

Y Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Xi Jinping's Vision for China's Financial Evolution

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Curaleaf Eyes Aurora Amid Alternative from Organigram

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

PRIMA Invests £10M to Propel CC Forum's Global Reach

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Class Action Targets Coastal Financial Over Missteps

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Atlas-SSI Expands Grip in Water Control Space

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Cloud Software Group Amends $2B Cash Tender Offer

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Differentia Bio's AI: Transforming Drug Development Dynamics

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Multiconsult's Q3 2026 Results: A Gradual Rebound

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...